相关人员
Ennio Schwind, LL.M. Eur.
Ennio is a member of the Patents Technology & Life Sciences Practice Area. His practice focuses on advising and representing national and international pharmaceutical companies and medical device manufacturers, with a particular emphasis on regulatory issues in the field of pharmaceutical and medical device law.
显示完整简历
隐藏完整简历
更多
显示更少
职业发展
| Since 2023 | Associate, Taylor Wessing |
| 2019 - 2021 | Graduate research assistant, Fieldfisher |
教育
| 2023 | Admission to the bar, Munich |
| 2022 | Second state law examination, Munich |
| 2020 - 2022 | Legal clerkship at the Higher Regional Court of Munich with a traineeship at Taylor Wessing |
| 2019 - 2020 | Master of Law (LL.M. Eur.) in European and International Business Law, Ludwig-Maximilians-University, Munich |
| 2020 | Semester abroad, University of Padua |
| 2019 | First State Examination in Law, Munich |
| 2013 - 2019 | Law studies, Ludwig-Maximilians-University, Munich |
Publications
Offene Fragen nach den neuesten EuGH-Urteilen zum Umpacken von Arzneimitteln, in: A&R 2023, zusammen mit Dr. Daniel Tietjen Artificial Intelligence Act (AIA) – neue Herausforderungen für Hersteller von KI-Medizinprodukten, in: ZdiW, Heft 12 2021, S. 458 ff., gemeinsam mit Dr. Daniel Tietjen Die behördliche Sonderzulassung von Medizinprodukten – zunehmende praktische Relevanz durch die Einführung der MDR, in: MPR, Heft 2 2020, S. 46 ff., gemeinsam mit Dr. Cord Willhöft |
语言
| English |
最新新闻和观点
酒店与休闲
点击此处了解更多
BGH restricts the granting of early payment discounts on prescription drugs
2024年2月28日
Quick read
品牌与广告业
点击此处了解更多
Regional Court of Karlsruhe: Advertising with the claims "climate-neutral" and "environmentally neutral product"
2023年12月18日
Quick read
酒店与休闲
点击此处了解更多
Draft of a cannabis law for the further legalisation of cannabis in Germany
2023年9月27日